Cargando…
Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature
BACKGROUND: Drug induced immune hemolytic anemia (DIIHA) is a rare complication and often underdiagnosed. DIIHA is frequently associated with a bad outcome, including organ failure and even death. For the last decades, ceftriaxone has been one of the most common drugs causing DIIHA, and ceftriaxone-...
Autores principales: | Leicht, Hans Benno, Weinig, Elke, Mayer, Beate, Viebahn, Johannes, Geier, Andreas, Rau, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203207/ https://www.ncbi.nlm.nih.gov/pubmed/30359322 http://dx.doi.org/10.1186/s40360-018-0257-7 |
Ejemplares similares
-
Ceftriaxone-Induced Immune Hemolytic Anemia
por: Singh, Anil, et al.
Publicado: (2020) -
Ceftriaxone-Induced Hemolytic Anemia in a Jehovah’s Witness
por: Tasch, James, et al.
Publicado: (2017) -
Ceftriaxone induced immune hemolytic anemia with disseminated intravascular coagulation
por: Shrimali, Jigar D., et al.
Publicado: (2013) -
An Uncommon Incidence of Drug-Induced Immune Hemolytic Anemia Secondary to Ceftriaxone
por: Sharma, Aishwarya, et al.
Publicado: (2021) -
Ceftriaxone-induced immune hemolytic anemia in a case with large vestibular aqueduct syndrome after cochlear implant
por: Wang, Yu, et al.
Publicado: (2019)